9alpha,13alpha,15,16-bisepoxy-3-oxolabdan-6beta,19-olide - Compound Card

9alpha,13alpha,15,16-bisepoxy-3-oxolabdan-6beta,19-olide

Select a section from the left sidebar

9alpha,13alpha,15,16-bisepoxy-3-oxolabdan-6beta,19-olide

Structure
Zoomed Structure
  • Family: Plantae - Lamiaceae
  • Kingdom: Plantae
  • Class: Ketone
Canonical Smiles C[C@@H]1OC[C@]2(C1)CC[C@@]1(O2)[C@H](C)C[C@@H]2[C@@H]3[C@]1(C)CCC(=O)[C@]3(C)C(=O)O2
InChI InChI=1S/C21H30O5/c1-12-9-14-16-18(3,6-5-15(22)19(16,4)17(23)25-14)21(12)8-7-20(26-21)10-13(2)24-11-20/h12-14,16H,5-11H2,1-4H3/t12-,13+,14-,16-,18+,19+,20-,21-/m1/s1
InChIKey ZJUKCJKMNOBEJA-YVUGOGEJSA-N
Formula C21H30O5
HBA 5
HBD 0
MW 362.47
Rotatable Bonds 0
TPSA 61.83
LogP 3.04
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.9
Exact Mass 362.21
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Leucas neufliseana Lamiaceae Plantae 2511971

Showing of synonyms

  • Ele S, G/Yesus T, et al. (2007). Chemical studies of Leucas martinicensis. M.Sc. Thesis, Addis Ababa University, Ethiopia,2007. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CC2OC(=O)C(C(=O)CC3)C2C3C1(O4)CCC45CCOC5

Level: 0

Mol. Weight: 362.47 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.59
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.74
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.65

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.6
Plasma Protein Binding
56.92
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
13.81
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.97
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.83
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
5.36
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-8.89
Rat (Acute)
2.37
Rat (Chronic Oral)
1.61
Fathead Minnow
3.82
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
413.45
Hydration Free Energy
-5.37
Log(D) at pH=7.4
2.4
Log(P)
1.97
Log S
-3.83
Log(Vapor Pressure)
-6.65
Melting Point
173.48
pKa Acid
8.05
pKa Basic
5.1
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7852
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7852
Beta-1 adrenergic receptor P07700 ADRB1_MELGA Meleagris gallopavo 3 0.7505
Beta-1 adrenergic receptor P07700 ADRB1_MELGA Meleagris gallopavo 3 0.7505
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 2 0.7120
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 2 0.7120

Download SDF